DUBLIN, Ireland and BRIDGEWATER, N.J., July 26, 2023 Amarin Corporation plc today announced the acceptance of funded research for presentation at the European Society of Cardiology Congress,.
- New Research Demonstrates Multifactorial Beneficial Effects of VASCEPA/VAZKEPA on Coronary Physiology and Plaque Progression - Data Further Advances Understanding of VASCEPA/VAZKEPA Potential Mechanism
— New Research Demonstrates Multifactorial Beneficial Effects of VASCEPA/VAZKEPA on Coronary Physiology and Plaque Progression — Data Further Advances Understanding of VASCEPA/VAZKEPA. | May 12, 2023
In older adults with HF, strong social support could affect kinesiophobia, or fear of movement, by influencing the severity of HF symptoms and improving disease self-care and symptom management, researchers reported. “Our recent study demonstrated that the incidence of kinesiophobia was as high as 63.14% in patients with chronic HF,” Kaizheng Gong, MD, PhD, of the department of